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Abstract: The present study was designed to investigate the influence of cytosolic Ca2+ 
concentration ([Ca2+]i) on action potential duration (APD) and on the incidence of early 
afterdepolarizations (EADs) in canine ventricular cardiomyocytes. Action potentials (AP) 
of isolated cells were recorded using conventional sharp microelectrodes and concomitant 
[Ca2+]i was monitored by the fluorescent dye, Fura-2. EADs were evoked at 0.2 Hz pacing 
rate by inhibiting the rapid delayed rectifier K+ current with dofetilide, by activating the 
late sodium current with veratridine, or by activating the L-type calcium current with BAY 
K8644. These interventions progressively prolonged the AP and resulted in initiation of 
EADs. Reducing [Ca2+]i by application of the cell-permeant Ca2+ chelator BAPTA-AM 
lengthened the AP at 1 Hz if it was applied alone or in the presence of veratridine and BAY 
K8644. BAPTA-AM, however, shortened the AP after pretreating the cells with dofetilide. 
The incidence of the evoked EADs was decreased by BAPTA-AM strongly in dofetilide 
and moderately in veratridine, while it was increased by BAPTA-AM in the presence of 
BAY K8644. Based on these experimental data changes in [Ca2+]i have marked effects on 
APD as well as on EAD incidence, however, the underlying mechanisms may be different 
depending on the mechanism of EAD generation. As a consequence, reduction of [Ca2+]i 
may eliminate EADs under some – but not all – experimental conditions. 
 
Key words: early afterdepolarizations, action potential duration, intracellular Ca2+ 
concentration, arrhythmogenesis, canine myocytes, electrophysiology, fluorescent Ca2+ 
indicator dyes, Ca2+ chelators. 
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Introduction 
 
Afterdepolarizations are defined as irregular membrane potential changes that disrupt the 
repolarization of the cardiac action potential. Early afterdepolarizations (EADs) appear 
during the plateau phase of an action potential with retarded terminal repolarization, while 
delayed afterdepolarizations (DADs) arise from the resting potential following complete 
repolarization (Hoffmann and Rosen 1981). Both types of afterdepolarizations may trigger 
extra action potentials in the neighboring cell, therefore they are considered as sources of 
cardiac arrhythmias including fatal ventricular fibrillation (Antzelevitch and Sicouri 1994). 
While DADs are known to be elicited by spontaneous Ca2+ release from the Ca2+-
overloaded sarcoplasmic reticulum (SR) leading to activation of Ca2+-dependent inward 
currents, the mechanism of generation of EADs is still controversial (Fozzard 1992). Since 
EADs are typically evoked by interventions shifting the net membrane current towards 
inward direction during the action potential plateau and appear usually at slow pacing 
frequencies, EADs were explained by reactivation of a potentially regenerative inward 
current system (Hoffmann and Rosen 1981, Marban et al. 1986, January et al. 1988, 
January and Riddle 1989, Fozzard 1992), e.g. reopening of L-type Ca2+ channels (Zeng and 
Rudy 1995, Viswanathan and Rudy 1999, Bányász et al. 2003). On the other hand, 
experimental results have revealed the occurrence of apparently spontaneous Ca2+ release 
events during some types of EADs, which might be considered as a trigger based on their 
peculiar timing, i.e. the rise in [Ca2+]i preceded depolarization similarly to observations 
made with DADs (Volders et al. 1997, Volders et al. 2000, Katra and Laurita 2005, 
Horvath et al. 2013). In the present study, therefore, the role of [Ca2+]i changes in EAD 
generation was studied using three different EAD models. Dofetilide (inhibitor of the rapid 
delayer rectifier K+ current, IKr), veratridine (activator of late Na+ current, INa-Late) and BAY 
K8644 (activator of L-type Ca2+ current, ICa) are equally suitable to evoke EADs, since all 
of them may increase APD in the required extent. In addition, they cause a comparable 
elevation of [Ca2+]i. On the other hand, BAY K8644 directly modulates the 
opening/reopening of Ca2+ channels, which is not the case with veratridine and dofetilide. 
After elaborating the optimal experimental design, [Ca2+]i was buffered following the 
development of EADs in each of the above models. This approach allowed to separate the 
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contribution of APD changes and [Ca2+]i changes to generation of EADs. Isolated canine 
ventricular myocytes were chosen to be studied because the electrical properties (action 
potential morphology as well as the density and kinetics of the underlying ion currents) of 
these cells most resemble those of human myocardium (Szentandrássy et al. 2005, Szabó et 
al. 2005). 
 
Materials and methods 
 
Isolation of single canine ventricular myocytes 
Adult mongrel dogs of either sex were anaesthetized with intramuscular injections of 
10 mg/kg ketamine hydrochloride (Calypsol, Richter Gedeon, Hungary) + 1 mg/kg 
xylazine hydrochloride (Sedaxylan, Eurovet Animal Health BV, The Netherlands) 
according to protocols approved by the local ethical committee (license No: 
18/2012/DEMÁB) in line with the ethical standards laid down in the Declaration of 
Helsinki in 1964 and its later amendments. Single myocytes were obtained by enzymatic 
dispersion using the segment perfusion technique, as described previously (Magyar et al. 
2000). Briefly, the heart was quickly removed and washed in cold Tyrode solution. A 
wedge-shaped section of the ventricular wall supplied by the left anterior descending 
coronary artery was dissected, cannulated and perfused with a nominally Ca2+-free Joklik 
solution (Minimum Essential Medium Eagle, Joklik Modification, Sigma-Aldrich Co. St. 
Louis, MO, USA) for 5 min. This was followed by 30 min perfusion with Joklik solution 
supplemented with 1 mg/ml collagenase (Type II, Worthington Biochemical Co., 
Lakewood, NJ, USA) and 0.2 % bovine serum albumin (Fraction V., Sigma) containing 
50 µM Ca2+. After gradually restoring the normal external Ca2+ concentration, the cells 
were stored in Minimum Essential Medium Eagle until use. 
 
Experiments on isolated cells 
All experiments were performed at 37 °C, maintained by an electronic temperature 
controller (Cell MicroControls, Norfolk, VA, USA). The rod-shaped viable cells showing 
clear striation were sedimented in a plexiglass chamber of 1 ml volume allowing 
continuous superfusion (at a rate of 2 ml/min) with Tyrode solution gassed with 100 % 
Page 4 of 21
https://mc06.manuscriptcentral.com/cjpp-pubs
Canadian Journal of Physiology and Pharmacology
Draft
 5
O2. The Tyrode solution contained (in mM): NaCl, 144; KCl, 5.6; CaCl2, 2.5; MgCl2, 1.2; 
HEPES, 5; and glucose 10; at pH=7.4. Action potentials of the isolated cells were 
monitored continously and the concomitant [Ca2+]i transients were recorded in (1) Tyrode 
solution, (2) in the presence of dofetilide, veratridine or BAY K8644, and finally, (3) 
following exposure to BAPTA-AM. Drugs were obtained from Sigma-Aldrich Co. (St. 
Louis, MO, USA) except for BAY K8644 (Biotrend Chemikalien GmbH, Cologne, 
Germany), and dofetilide (Egis Pharmaceuticals Ltd., Budapest, Hungary). 
 
Electrophysiology 
Transmembrane potentials were recorded using 3 M KCl filled sharp glass 
microelectrodes having tip resistance between 20 and 40 MΩ. These electrodes were 
connected to the input of Multiclamp 700A or 700B amplifiers (Molecular Devices, 
Sunnyvale, CA, USA). The cells were paced through the recording electrode at steady 
cycle length of either 1 s (when recording action potentials -see Figs. 1-2) or 5 s (when 
recording EADs and [Ca2+]i transients simultaneously - see Figs. 3-6) using 1-2 ms wide 
rectangular current pulses having amplitudes of twice the diastolic threshold. Since the 
cytosol was not dialyzed, time dependent changes in action potential morphology were 
negligible for the period of our experimental protocol lasting typically not longer than 45 
min. Action potentials were digitized (at 200 kHz using Digidata 1322A, 1440A and 
1200 A/D card, purchased from Axon Instruments Inc., Foster City, CA, USA) and stored 
for later analysis. 
 
Recording of cytosolic Ca
2+
 concentration 
[Ca2+]i transients were assessed together with the transmembrane potential changes using 
the ratiometric dye, Fura-2, as described previously (Szigeti et al. 2000). Myocytes were 
loaded with the membrane-permeant form of Fura-2 (3 µM Fura-2-AM) for 30 min at 
room temperature in the presence of Pluronic F-127, then the cells were stored at 15 °C 
before the measurements. Cells were placed in a superfusion chamber on the stage of an 
inverted microscope (Eclipse TE2000-U, Nikon, Japan), warmed to 37 °C and viewed 
using a 40x oil immersion objective (CFI S-Fluor 40x oil, Nikon, Japan). 
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Fura-2 was excited with 340 and 380 nm monochromatic light. A xenon arc lamp (Ushio 
Deutschland GmbH, Steinhöring, Germany) was used as light source. Excitatory 
wavelengths were altered by a dual-wavelength excitation monochromator and an on-line 
connected computer (DeltaScan, Photon Technology International, New Brunswick, NJ, 
USA). Fluorescence emission was monitored at 510 nm using a R1527P photomultiplier 
tube (Hamamatsu Photonics Deutschland GmbH., Herrsching am Ammersee, Germany) 
at an acquisition rate of 200 Hz. Changes in intracellular free Ca2+ levels were 
approximated by the ratio of the fluorescence intensity obtained at 340 and 380 nm 
excitation after correction for nonspecific background fluorescence and recorded using 
FeliX32 Software & BryteBox Interface (Photon Technology International, New 
Brunswick, NJ, USA). Ten consecutive calcium transients were analyzed under each 
condition. 
 
Determination of beat-to-beat variability of APD 
Beat-to-beat variability of action potential duration was determined at 0.2 Hz when EADs 
were typically displayed. The series of 30 consecutive action potentials were analyzed to 
estimate variability according to the following formula: 
V = Σ (│APDn+1 minus APDn│) / [nbeats * √2] 
where V is variability of APD, APDn and APDn+1 indicate the durations of the nth and 
n+1th action potentials, respectively, measured at 90% level of repolarization and nbeats 
denotes the number of consecutive beats analyzed. 
 
Determination of EAD frequency 
EADs were defined as inflexion of membrane potential change during the course of 
repolarization exceeding 3 mV in amplitude. EAD frequency was defined as the 
percentage of APs where at least 1 EAD could be observed. EAD frequency was 
determined for each cell using 30 consecutive action potentials in Tyrode solution, after 
10 min of superfusion with dofetilide, veratridine or BAY K8644, and finally, after 30 
min of superfusion with 5 µM BAPTA-AM. 
 
Statistics 
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Results are expressed as mean ± SEM values. Statistical significance of differences was 
evaluated using one-way ANOVA followed by Student's t-test. Changes in the absolute 
number of EADs before and after BAPTA-AM application were evaluated by Fisher’s 
exact test. Differences were considered significant when p was less than 0.05. 
 
Results 
 
Effects of BAPTA-AM on action potential duration at 1 Hz 
Since the central issue of the present work was to study the effects of [Ca2+]i changes on 
EAD generation, the concentration-dependent effects of dofetilide, veratridine and BAY 
K8644 (agents used to evoke EADs at low stimulation frequencies) on APD was studied at 
the pacing frequency of 1 Hz. At this fast driving rate EAD generation was absent, 
allowing direct comparison of drug-effects on APD within a relatively wide concentration 
range. According to the results presented in Fig.1, APD was increased significantly by all 
the three agents in a concentration-dependent manner. Moreover, these effects were 
practically identical at the concentration of 100 nM: the APD lengthening effects of 
dofetilide, veratridine and BAY K8644 were 84±6 ms (n=30), 76±7 ms (n=19) and 87±6 
ms (n=6), respectively. Higher concentrations of veratridine and dofetilide caused larger 
lengthening of APD, while the effect of BAY K8644 was saturated at 100 nM. 
Prolongation of APD was accompanied by a marked upward shift in the plateau potential in 
the case of BAY K8644 and in a less pronounced way in the case of veratridine. 
 All of the above mentioned treatments increase [Ca2+]i by different means. BAY 
K8644 increases ICa leading to a directly increased Ca2+ entry into the cells. Dofetilide 
prolongs the AP indirectly letting more Ca2+ to enter into the cells during the longer open 
state of the L-type calcium channels. Veratridine increases [Na+]i and causes a reduced 
calcium extrusion through the sodium-calcium exchanger. In order to study the effects of 
[Ca2+]i changes on APD under the conditions above, [Ca2+]i was reduced by a Ca2+ 
chelator. The cells were loaded with the cell-permeant acetoxy-methylesther form of the 
Ca2+ chelator BAPTA (BAPTA-AM) and the cells were allowed to release BAPTA 
intracellularly as a consequence of intracellular esterase activity. As demonstrated in Fig. 
2.A, superfusion with 5 µM BAPTA-AM for 30 min progressively increased APD. The 
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configuration of action potentials was also characteristically altered: the plateau potential 
was markedly elevated by BAPTA-AM, a change congruent with larger amplitude of ICa 
due to diminished Ca2+-dependent inactivation. APD was increased by BAPTA-AM alone 
as well as when BAPTA-AM was applied in the presence of veratridine or BAY K8644, 
but not after pretreatment with dofetilide (Fig. 2.B-E). Actually veratridine and BAY 
K8644 significantly enhanced the APD lengthening effect of BAPTA-AM, while a 
significant APD shortening was observed when the cells were exposed to BAPTA-AM in 
the presence of dofetilide (Fig.2.F). 
 
Effects of BAPTA-AM on EAD incidence at 0.2 Hz 
In each of the three EAD models studied drug-effects were combined with consequences of 
slow driving rate. Dofetilide strongly lengthened APs and increased the beat-to-beat 
variability of APD markedly, which was accompanied by development of EADs in all of 
the 10 cells exposed to 300 nM dofetilide for 10 min. In 6 of these cells EADs were present 
continuously, while in 4 cells the frequency of EAD varied between 20 % and 70 % of the 
total recording period. All these changes were reverted by superfusion of 5 µM BAPTA-
AM for 30 min, although the reversion was not complete. EADs fully disappeared in 8 out 
of the 10 cells, and an EAD frequency of only 20-40 % was obtained in the remaining 2. 
The high average value of EAD frequency observed in dofetilide (77±10%) was decreased 
to 5±4 % in the presence of BAPTA-AM (p<0.05, n=10). APD variability was also reduced 
significantly by BAPTA-AM (Fig. 3). 
 In the presence of 300 nM veratridine EAD frequency was lower than observed 
with dofetilide. This could not been overcome even if the concentration of veratridine was 
elevated up to 1 µM (not shown). Although EADs developed in all of the 18 cells exposed 
to veratridine, the average frequency of EADs was only 37.4±6.4 %, which was reduced by 
BAPTA-AM superfusion to 22.4±6.0 % (p<0.05, n=18). Similarly to EAD frequency, the 
variability of APD was also moderately but significantly diminished by BAPTA-AM (Fig. 
4). 
 EADs developed in 16 out of the 21 cells exposed to 200 nM BAY K8644, 
displaying an EAD frequency of 56.8±9.2 %. APD variability was also increased - 
similarly to results obtained with dofetilide or veratridine. In contrast to these results, 
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however, superfusion with BAPTA-AM further increased EAD-frequency to 70.4±8.2 % 
(p<0.05, n=21) since 19 cells displayed EADs following BAPTA-AM superfusion, while 
APD variability remained unaltered (Fig. 5). 
 
Effects of BAPTA-AM on [Ca
2+
]i transients at 0.2 Hz 
Using the same protocol applied for EAD measurements, changes in cytosolic free Ca2+ 
concentration was recorded in the presence of 300 nM dofetilide, 300 nM veratridine and 
200 nM BAY K8644 (Fig. 6). Diastolic and systolic [Ca2+]i levels were significantly 
increased by all of these drugs, resulting in drastic increases in [Ca2+]i transient amplitudes. 
These changes in the peak [Ca2+]i values and [Ca2+]i amplitudes were readily reverted by 
exposure to 5 µM BAPTA-AM for 30 min, furthermore, [Ca2+]i amplitudes were 
significantly lower than their respective control values in the case of dofetilide and BAY 
K8644, but not in the case of veratridine. Diastolic [Ca2+]i, however, further increased 
during the time of BAPTA-AM superfusion. 
 
Discussion 
In the present study the effect of [Ca2+]i changes on the incidence of EADs were studied 
using three models of EADs. EADs were evoked by IKr blockade (dofetilide), activation of 
INa-Late (veratridine) and activation of ICa (BAY K8644). Each of these interventions 
resulted in initiation of EADs at 0.2 Hz pacing frequency. Superfusion of the myocytes 
with the Ca2+ chelator BAPTA-AM (in the continuous presence of the previously applied 
agent) decreased [Ca2+]i drastically, while its effect on the EAD frequency was variable 
depending on the actual combination of APD and [Ca2+]i changes. BAPTA-AM markedly 
reduced APD as well as EAD frequency in the presence of dofetilide, emphasizing the 
primary role of APD lengthening in the generation of EADs (January et al. 1991, January 
and Moscucci 1992). On the other hand, both APD and EAD frequency were increased by 
BAPTA-AM in the presence of BAY K8644 - in accordance with the concept above. 
However, if EAD incidence was dependent exclusively on APD, BAPTA-AM should have 
increased EAD frequency in veratridine due to the strong APD lengthening effect of 
BAPTA-AM in veratridine (as demonstrated in Fig. 2.C and F). Clearly, this was not the 
case, since chelation of [Ca2+]i decreased EAD frequency (and also variability of APD) 
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after veratridine treatment. More explicitely, BAPTA-AM decreased EAD frequency in 
spite of its APD lengthening effect. This is an evidence indicating that elevation of [Ca2+]i 
is really a considerable factor of EAD incidence, capable to generate both types of 
afterdepolarizations. 
Another argument against the exclusive role of APD in EAD generation arises 
when the effects of BAPTA-AM in the presence of BAY K8644 and veratridine are 
compared. BAPTA-AM evoked comparable prolongations of APD in the presence of the 
two agents (Fig. 2.F), while its effect on EAD frequency was the opposite in BAY K8644 
(enhancement) and veratridine (reduction). Taking into account that the effect of BAPTA-
AM on [Ca2+]i transients was similar in veratridine and BAY K8644 (in fact, the amplitude 
of [Ca2+]i transient was even reduced below the control level by BAPTA-AM in BAY 
K8644) ) the divergent effects on EAD frequency cannot be attributed to changes in [Ca2+]i. 
It is likely that the augmentation of ICa by BAY K8644 - resulting in a larger population of 
Ca2+ channels mediating more late Ca2+ current - is the substrate for the enlarged EAD 
frequency in BAY K8644, which was further aggravated by reduction of [Ca2+]i probably 
due to shifting the Ca2+ channels towards a non-inactivated state. 
In summary, changes in [Ca2+]i may have marked effects on EAD incidence, 
however, the underlying mechanisms may be different depending on the mechanism of 
EAD generation. As a consequence, reduction of [Ca2+]i may eliminate EADs under some - 
but not all - experimental conditions. 
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Figure legends 
 
Fig.1.  Concentration-dependent effects of dofetilide (A, B), veratridine (C, D), and BAY 
K8644 (E, F) on action potential configuration (A, C, E) and duration (B, D, F) at 1 Hz. 
Each drug concentration was applied for 5 min. Columns and bars are means ± SEM, 
asterisks denote significant changes from control, numbers in parentheses indicate the 
number of cells studied. 
 
Fig.2.  Time-dependent effects of 5 µM BAPTA-AM alone (n=18, A, B), in the presence of 
100 nM veratridine (n=7, C), 100 nM BAY K8644 (n=6, D) and 100 nM dofetilide (n=7, 
E) at 1 Hz. Superfusion with BAPTA-AM started after 5 min period of drug-pretreatment. 
Open circles denote data without BAPTA-AM (with or without drug-pretreatment), filled 
circles represent APD values observed in the presence of BAPTA-AM. Average results 
obtained at the 15th and 25th min of superfusion with BAPTA-AM are presented in panel F. 
Symbols, columns and bars indicate means ± SEM, asterisks denote significant differences 
between pre-BAPTA-AM and post-BAPTA-AM values, + symbols in panel F indicate 
significant differences in actions of BAPTA-AM after drug-pretreatment versus BAPTA-
AM alone. 
 
Fig.3.  Effect of BAPTA-AM on EAD incidence in the presence of dofetilide at 0.2 Hz. 
Representative records of membrane potential changes (A, B, C) and cytosolic Ca2+ signals 
(D, E, F) obtained in control (A, D), in the presence of 300 nM dofetilide for 10 min (B, E) 
and after superfusion with 5 µM BAPTA-AM in the presence of dofetilide for 30 min (C, 
F). G, H: Average results obtained on EAD frequency (G) and APD variability (H) in 10 
myocytes. Each small open circle in panel G represents an individual cell showing its EAD 
frequency, filled squares indicate average values. Symbols, columns and bars indicate 
means ± SEM, asterisks denote significant differences from control, + symbols indicate 
BAPTA-AM induced significant changes. 
 
Fig.4.  Effect of BAPTA-AM on EAD incidence in the presence of veratridine at 0.2 Hz. 
Representative records of membrane potential changes (A, B, C) and cytosolic Ca2+ signals 
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(D, E, F) obtained in control (A, D), in the presence of 300 nM veratridine for 10 min (B, 
E) and after superfusion with 5 µM BAPTA-AM in the presence of veratridine for 30 min 
(C, F). G, H: Average results obtained on EAD frequency (G) and APD variability (H) in 
18 myocytes. Each small open circle in panel G represents an individual cell showing its 
EAD frequency, filled squares indicate average values. Symbols, columns and bars indicate 
means ± SEM, asterisks denote significant differences from control, + symbols indicate 
BAPTA-AM induced significant changes. 
 
Fig.5.  Effect of BAPTA-AM on EAD incidence in the presence of BAY K8644 at 0.2 Hz. 
Representative records of membrane potential changes (A, B, C) and cytosolic Ca2+ signals 
(D, E, F) obtained in control (A, D), in the presence of 200 nM BAY K8644 for 10 min (B, 
E) and after superfusion with 5 µM BAPTA-AM in the presence of BAY K8644 for 30 
min (C, F). G, H: Average results obtained on EAD frequency (G) and APD variability 
(H) in 21 myocytes. Each small open circle in panel G represents an individual cell 
showing its EAD frequency, filled squares indicate average values. Symbols, columns and 
bars indicate means ± SEM, asterisks denote significant differences from control, + 
symbols indicate BAPTA-AM induced significant changes. 
 
Fig.6.  Effect of BAPTA-AM on intracellular Ca2+ transients recorded in the presence of 
dofetilide (A-C), veratridine (D-F) and BAY K8644 (G-I) at 0.2 Hz. The experimental 
protocol was identical to that used in Figs. 3-5. Diastolic (A, D, G), systolic [Ca2+]i (B, E, 
H), as well as the amplitude of the [Ca2+]i transient (C, F, I) are expressed as fluorescent 
ratios (F340 / F380). Columns and bars indicate means ± SEM, asterisks denote significant 
differences from control, + symbols indicate BAPTA-AM induced significant changes. 
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